Research

NYU Medical Center Home

NYU School of Medicine Home

Research Home

Administration

CONTACT

DIRECTORY

>	VIPS (Become a Research Volunteer)
>	Administration
>	NYU Urology Associates
>	FIND A DOCTOR
>	Prepare for Surgery, Heal Faster


		E-mail Page

		Print Page

		Calendars

Naomi Howe, M.Sc., Assistant Research Scientist, assists Paul D. Walden, Ph.D., Assistant Professor of Urology and Biochemistry

Active NIH Grants

NIH NIDDK 1 P01DK52206-01A1: Growth Differentiation and Disease of Urothelium. The Program Project. 1999-2003 (Sun) $6,141,860.

NIH Androgen Receptor Regulation of Prostate Cancer Growth: 7/1/98 - 6/30/03 (Taneja) $438,534.

NCI CA 72290 : Prostate Cancer Chemoprevention Clinical Clinical Trials: 2/97 - 1/02 (Melamed) $1,360,525. The major goals of this project are to develop a chemoprevention method for prostate cancer and to develop a practical approach for testing prostate cancer chemoprevention efficacy in clinical trials.

NIH DK 49469: Transgenic Mouse Studies Of Bladder Muscosal Disease. 10/94 - 9/99 (SUN) $589,005.

NIH DK 39753: Biochemistry of Urothelial Differentiation. 3/96 - 2/01 $659,595.

NIH NCI CA 64709: Mammary Caccinogenesis Growth Hormone and IGF-1. 8/96 - 7/01 (Walden & Kleinberg-Co-investigators) $915,340. The major goals of this project are to determine the role of growth hormone induced IGF-I in mammary development.

NIH DK 52634. The Biology of Prostate Stem Cells. 7/97 - 5/02 (Wilson) $ 783,010.

NIH DK 53063: Skin-CNS-Bladder Reflex ARC for Micturition after SCI. 9/99 - 12/04 (XIAO) $2,847,918

NIH NCI CA58088: Perinatal hormonal factors and rat prostate carcinogenesis. 9/92-7/98 (Bosland) $1,006,872.

NIH 1 T32 DK 07775: Urological Research Training Grant: 7/99 - 6/04 (Lepor) Annual Direct Costs: $92,181. The goals of this application are to provide broad-based Urological Research Training for PhD fellow.

NIH R01 DK 56170: Sympathetic Nervous System and Prostatic Hyperplasia. 7/99 - 6/03 (Walden)

Annual Direct Costs: $136,642. The major goals of this project are to determine the role of the sympathetic neurotransmitters in the pathogenesis of benign prostatic hyperplasia.

NIH CA 84441: The BTG2 antiproliferative gene and prostate cancer progression. 12/99-11/04 (Walden) Annual Direct Costs: $125,505. The major goals of this project are to determine the role of the BTG2 antiproliferative gene in prostate cancer progression by examining the expression and functional consequences of BTG2 expression in prostate cells.

NIH CA 86772-01: The NYU Cooperative Prostate Tissue Resource 5/2000 - (Melamed) $300,000. Pathology tissue bank